Ads
related to: trulicity- Savings Card
Find Out If You Qualify For
The Trulicity® Savings Offer.
- Starting Trulicity®
Learn What To Expect When
You Take Trulicity.
- How To Use Trulicity®
Discover Ways To Establish A Good
Routine, How To Use & More.
- About Trulicity®
Learn What Trulicity Is, How it
Works, and How It Can Help.
- Official Physician Site
Official Trulicity® HCP Site
for Health Care Professionals.
- En Español
Find Official Trulicity® Site
And Resources in Spanish.
- Savings Card
Search results
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 1 day agoThis pushed Lilly to raise its sales outlook for the year by $2 billion, despite short revenue from...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 2 days agoIn the first quarter, sales of both rocketed higher, but only Zepbound sales topped expectations....
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks· 2 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoHowever, this was partially offset by decreased sales of Trulicity. The company's net income and...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 23 hours agoDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before...
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Benzinga via Yahoo Finance· 2 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press via Yahoo Finance· 2 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 18 hours agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 2 days agoLilly noted that its so-called “incretin medicines” — a group that also includes its earlier...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 2 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
Ads
related to: trulicity